Skip to main content

Table 3 Biosocial characteristics of adherents and nonadherent hypertensive people to antihypertensive drug treatment during the COVID-19 pandemic (n = 281)

From: Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study

Variable

Adherence

P-value

Yes

No

Total

Sex

   

0.575a

 Female

105 (63.6)

70 (60.3)

175 (62.3)

 

 Male

60 (36.4)

46 (39.7)

106 (37.7)

 

Skin color

   

0.001b

 White

111 (67.3)

59 (50.9)

170 (60.5)

 

 Black

28 (17.0)

41 (35.3)

69 (24.6)

 

 Brown/yellow

26 (15.8)

16 (13.8)

42 (14.9)

 

Marital status

   

0.309a

 Married

75 (45.5)

57 (49.1)

132 (47.0)

 

 Unmarried

34 (20.6)

31 (26.7)

65 (23.1)

 

 Divorced

16 (9.7)

9 (7.8)

25 (8.9)

 

 Widow

40 (24.2)

19 (16.4)

59 (21.0)

 

 Age (yr)

67 ± 14

64 ± 14

66 ± 14

0.044c

 Education (yr)

9.0 ± 4.2

9.1 ± 4.4

9.0 ± 4.0

0.613a

Currently work

 Yes

34 (20.6)

34 (29.3)

68 (24.2)

 

 No

131 (79.4)

82 (70.7)

213 (75.8)

0.093a

 Individual monthly income (US$)

308.57 ± 247

350.39 ± 225

325.70 ± 238

0.149c

 Family monthly income (US$)

527.98 ± 508

512.32 ± 288

521.53 ± 431

0.745c

  1. Data are presented as number (%) or mean ± standard deviation
  2. P-value obtained by aPearson chi-test,
  3. bFisher exact test, and
  4. ct-test